Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Omeros (OMER) Worth A Look: Stock Adds 11.8% In Session

Published 06/13/2017, 08:30 AM
Updated 07/09/2023, 06:31 AM
OMER
-
BIO
-

Omeros Corporation (NASDAQ:OMER) was a big mover last session, as the company saw its shares rise almost 12% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $14.95 to $16.44 in the past one-month time frame.

The company has seen two negative estimate revisions in the last 30 days and the Zacks Consensus Estimate also moved lower suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Currently, Omeros carries a Zacks Rank #3 (Hold).

A better-ranked stock in the same industry is Bio-Rad Laboratories, Inc. (NYSE:BIO) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is OMER going up? Or down? Predict to see what others think: Up or Down

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time. One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Bio-Rad Laboratories, Inc. (BIO): Free Stock Analysis Report

Omeros Corporation (OMER): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.